All News

Pharmaceutical Representative

According to a study in the Journal of the American Medical Association (vol. 283, no. 8) prescriptions of mood-altering drugs in two to four year olds increased from the years 1991 to 1995. The study examined three psychotropic medication classes: stimulants, antidepressants and neuroleptics, and looked at pharmacy data in patients from two Medicaid programs and one HMO finding that "Sizeable increases in prevalence were noted between 1991 and 1995 across the three sites for clonidine, stimulants and antidepressants while neuroleptic use increased only slightly." The study concluded, however, that, because of the number of medications with off-label indications, community-based, multidimensional outcome studies would be called for.

Pharmaceutical Representative

President Clinton received and endorsed a set of "Prescription Drug Principles" from Senate Democratic Leader Tom Daschle (D-SD), which will be used by the Senate Democratic Caucus to evaluate any Medicare prescription drug benefit proposal developed in Congress. The principles state that any drug benefit should be: voluntary, accessible to all beneficiaries, designed to provide meaningful protection and bargaining power for seniors, affordable for all beneficiaries and for the program, administered using competitive purchasing techniques and consistent with broader Medicare reform.

Pharmaceutical Representative

Researchers at the Duke University Medical Center have discovered that HIV patients who take fewer pills tend to do better than patients on a more complex medical regimen. Based on an analysis of more than 3,000 patients involved in triple-drug combination trials to treat HIV infection, researchers speculate that patients who take fewer pills, as few as four a day, are more likely to adhere to their medication regimen - and therefore receive the greatest benefits of the therapy – than those on complex regimens who must take up to 16 pills at different times during the day.

Pharmaceutical Representative

Results of a new survey detailing the attitudes of consumers toward direct-to-consumer print and television advertising for pharmaceuticals have been released by the Food and Drug Administration's Division of Drug Marketing, Advertising and Communications.

Pharmaceutical Representative

A new study by Management Recruiters International, a Cleveland-based search and recruitment company, shows that, as the Internet has become increasingly popular in the workplace, many pharmaceutical companies are adopting formal policies about its use.

Pharmaceutical Representative

Pfizer Inc., New York, and Warner-Lambert Co., Morris Plains, NJ, announced they have entered into a definitive merger agreement. The combined company will have annual revenues of approximately $28 billion, including $21 billion in prescription pharmaceutical sales.

Pharmaceutical Representative

The National Institutes of Health's National Institute of Allergy and Infectious Disease recently issued an updated version of the "Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents" at www.hivatis.gov.

Pharmaceutical Representative

Physician prescribing habits can be influenced by samples, continuing medical education sponsorships and conference travel funding, according to a study published in the Journal of the American Medical Association (vol. 283, no. 3).

Managed care Q&A

Pharmaceutical Representative

Without a doubt, managed care has had a huge impact on the way physicians conduct their practices and the amount of time they have to spend with pharmaceutical reps. With these issues in mind, Pharmaceutical Representative asked Mark Callahan, director of outcomes-based research for the New York and Presbyterian Hospital Care Network, a few questions about where the managed care industry stands at the beginning of the 21st century and the issues taking shape there.

Pharmaceutical Representative

Results of a study conducted by researchers at the National Institutes of Health Clinical Center show that St. John's wort, an herbal product used to treat depression, could significantly undermine the effectiveness the antiviral drug indinavir, which is often prescribed to treat HIV infection.

Pharmaceutical Representative

According to the Pharmaceutical Research and Manufacturers of America, at its annual state of the industry conference in Washington, pharmaceutical and biotechnology companies had 40 new treatments – 35 drugs and five biologics – approved by the Food and Drug Administration in 1999. The medicines target 36 diseases that affect 545 million patients and cost society an estimated $600 billion a year.

Pharmaceutical Representative

Drug cost increases will exceed 18% for 2000 – leading to a significant increase in total health plan costs - according to a study from the Segal Co., a consultant and actuary firm serving human resources, employee benefits and compensation programs in the U.S., Canada and abroad.

Pharmaceutical Representative

In a merger of equals valued at $75 billion, London-based Glaxo Wellcome Inc., and SmithKline Beecham, also based in London, have agreed to join businesses – forming the largest pharmaceutical company in the world. The new company, which would be known as Glaxo SmithKline, would have an annual research and development budget of approximately $4 billion.

Pharmaceutical Representative

Christine Garabedian knew, for more than two years, what she wanted to do. She described her experience in physicians' offices: "I'd see the reps talking to doctors and I thought, 'That's what I want to do - how come no one lets me do this?' I knew I'd be good at it."

Pharmaceutical Representative

"Pharmaceutical Sales Force Structures & Strategies 1999-2000," a survey of U.S. physicians released by Newtown, PA-based pharmaceutical consulting company Scott-Levin, reveals that doctors rank Pfizer Inc.'s sales force as the most valuable. Twenty-eight physician specialty groups in nine core specialty areas – general/family practitioners, internists, pediatricians, orthopedic surgeons, obstetricians/gynecologists, psychiatrists, general surgeons, gastroenterologists and cardiologists – were surveyed for this year's study. 1999 was the fifth consecutive year New York-based Pfizer finished first across the core groups.

Mammograms:Necessary?

Pharmaceutical Representative

A Danish study published in the British journal The Lancet suggests that mammograms may be unjustified in attempting to screen for breast cancer.

Pharmaceutical Representative

The Food and Drug Administration is warning patients taking Titusville, NJ-based Janssen Pharmaceutica's heartburn treatment, Propulsid® (cisapride) of new advisories concerning the drug. Propulsid is a treatment for severe nighttime heartburn in patients with gastroesophagal reflux disease who do not adequately respond to other therapies. The new measures are being recommended to help physicians avoid giving Propulsid to patients who are at known risk of rare, but serious, cardiac events associated with the drug.

Pharmaceutical Representative

Reps need to spend time planning, account targeting and learning about new managed care tools that drive today's operations as well as prepare us for tomorrow's growth businesses.

Pharmaceutical Representative

Schering-Plough Corp., Madison, NJ, has announced the launch of a new, 120-member primary care sales force to complement its existing hepatitis C sales team. The new force is being acquired from Triangle Park, NC-based Innovex.

Pharmaceutical Representative

A last-minute provision, passed with budget legislation, may give Massachusetts a state-run bulk pharmaceutical purchasing program.

Pharmaceutical Representative

The proposed merger between Abbott Laboratories and Alza Corp. will not be completed due to an inability to come to terms with the FTC.

Pharmaceutical Representative

Since sales success starts by reaching the decision-maker, sales representatives must find creative ways to penetrate the barriers that surround the toughest accounts.

Pharmaceutical Representative

Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.